✦ LIBER ✦

Optimizing bioavailability in the treatment of Parkinson's disease

✍ Scribed by Lauren C. Seeberger; Robert A. Hauser

Book ID: 116784901
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 268 KB
Volume: 53
Category: Article
ISSN: 0028-3908
DOI: 10.1016/j.neuropharm.2007.08.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimizing treatment for Parkinson's dis

Optimizing treatment for Parkinson's disease

✍ Schapira, A. H. V.; Tan, E. K. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB

Treatment of Parkinson's disease

✍ Mariese A. Hely; Victor S.C. Fung; John G.L. Morris 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Treatment of Parkinson’s Disease

✍ Matthias Fargel, Bernd Grobe, Eberhard Oesterle, Claudia Hastedt, Dr Markus Rupp 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 128 KB

Entacapone in the treatment of Parkinson

Entacapone in the treatment of Parkinson's disease

✍ Anette Schrag 📂 Article 📅 2005 🏛 The Lancet 🌐 English ⚖ 146 KB

Selegiline in the treatment of Parkinson

Selegiline in the treatment of Parkinson's disease

✍ Heinonen E H; Rinne U K 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

Levodopa in the treatment of Parkinson’s

Levodopa in the treatment of Parkinson’s disease

✍ A. H. V. Schapira; M. Emre; P. Jenner; W. Poewe 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB